Business Wire

MARJAN

1.1.2019 14:55:10 CET | Business Wire | Press release

Share
2019 Ras Al Khaimah New Year’s Eve Fireworks captivates the world with a breathtaking spectacle

Ras Al Khaimah captivated the world with its 2019 New Year’s Eve Fireworks that welcomed hundreds of thousands of visitors to the emirate. Organised by Marjan, with the support of Ras Al Khaimah’s government entities, and put together by Fireworks by Grucci, the Ras Al Khaimah New Year’s Fireworks, spanning a duration of over 13.20 minutes, also clinched two Guinness World Records for the ‘Longest chain of fireworks’ and the ‘Longest straight line of fireworks’.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190101005028/en/

This year, the celebration was made even more memorable for the visitors with Al Marjan Island, the venue of the event and the flagship lifestyle destination by Marjan, hosting several family-oriented activities. Positioning the event on the global map of New Year’s Eve celebrations, the Ras Al Khaimah event was telecast internationally, and its images and videos shared on social media by millions more.

Eng. Abdulla Al Abdouli, Managing Director & CEO of Marjan, said: “The spectacular event highlighted the reputation of Ras Al Khaimah as the must-visit destination for celebrating the New Year’s Eve. With visitors arriving from across the world, the event served to highlight the touristic appeal of Ras Al Khaimah and to position it as a fast-growing leisure and commercial hub in the region. We thank the leadership of Ras Al Khaimah for their guidance and support in accomplishing this event, and all the government entities in the Emirate for the exceptional team work. With two Guinness World Records set, the 2019 Ras Al Khaimah New Year’s Eve Gala has been truly historic and adds to the pride of our nation.”

The celebration flagged off with a fascinating pyrotechnic tribute to the late Sheikh Zayed bin Sultan Al Nahyan, the founding father of the nation. In a befitting conclusion to the ‘Year of Zayed’ marked in 2018 to coincide with his birth centenary, the night-sky of Ras Al Khaimah came to life with a brilliant image of Sheikh Zayed followed by a magnificent fireworks display.

“With our tribute to the late Sheikh Zayed, we highlighted that his legacy and name is important for us – daily, every hour and every second of the day. For us, Zayed is the beginning of everything we do; Zayed is the start of every new challenge; Zayed is our sense of pride. And we are starting the year, once again, remembering and paying respect to our great leader,” said Eng. Al Abdouli.

The ‘Longest chain of fireworks’

Clinching the Guinness World Records for the ‘Longest chain of fireworks’, the first pyrotechnic display, the tribute to the late Sheikh Zayed, featured 11,284 firework devices. The earlier record was for deploying 10,005 firework devices set by Viejas Casino & Resort (USA) in Alpine, California, USA, on September 12, 2014. Fireworks were deployed from 52 sites along Al Marjan Island and the waterways of Ras Al Khaimah’s coastline, with the total length of the chain exceeding 4.6 kilometres. The show was designed to 12 international music compositions, and the record was set in just 40 seconds.

The ‘Longest straight line of fireworks’

This was followed drone countdown to the New Year. A canopy of golden showers followed, and Ras Al Khaimah won the Guinness World Records for the ‘Longest straight line of fireworks’. The stunning display spanned an area of 13 kilometres, trumping the earlier record set over a distance of 11.38 kilometres.

The display had the largest calibre of aerial shell at a diameter of 600 mm, the largest used in the UAE for any fireworks display during this New Year’s Eve. The record was set in 12.06 minutes, with fireworks positioned at 13 sites across Al Marjan Island and the waterways along the RAK shoreline. There were seven themed chapters for the show, which was set to international music compositions. The inspiration for the fireworks display was the natural beauty of Ras Al Khaimah, and it was choreographed to highlight the beautiful beaches and resorts along the Emirate’s shoreline.

SkyMagic Drone Show

A 200-piece SkyMagic drone show was precisely integrated into the fireworks design. Scenes such as the tribute to Sheikh Zayed were displayed within a 100m space in the sky accented by colourful bursts of fireworks. A sweeping display of a falcon spreading its wings emphasised the heritage of the Emirate.

Designed by Phil Grucci, CEO & Creative Director of Fireworks by Grucci, the event was verified by an official adjudicator from Guinness World Records for the ‘Longest chain of fireworks’ and the ‘Longest straight line of fireworks.’ Following the fireworks gala, Eng. Al Abdooli and Phil Grucci, received the Guinness World Records titles from the adjudicator.

Marjan worked closely with Ras Al Khaimah’s government entities including Ras Al Khaimah Public Works to create several public viewing areas across Al Marjan Island. More than 27,000 additional public car parking spaces were provided to welcome the guests.

Preparations for the 2019 Ras Al Khaimah New Year’s Eve Fireworks started in early 2018 immediately after the successful Guinness World Record achievement for the ‘Largest Aerial Shell’ displayed from Al Marjan Island at last year’s New Year’s Eve celebration.

Over 300 hours were spent to design the show. The design resulted in the programming of over 41,000 lines of computer instructions to control 20 computers to display the sweeping performance. The firework components for the aerial shells, ranging in size from 14 to 600 mm, were hand-crafted exclusively by Grucci in their factories in New York and Virginia over a two-month period.

This time, Marjan had added new viewing areas for more people to enjoy the show. Several family activities were hosted at the venue including food trucks, ice cream salons, lemonade corners, colourful band performances, and face painting and inflatable games for children. Stilt walkers, mime artists, and clowns welcomed the guests.

For more information, please visit: www.RAKNYE.com

*Source: AETOSWire

Contact:

ASDA’A BCW Iman Ahmed | Anthony Fernandes | Ahmed Abdulrazek Tel: +97144507600 iman.ahmed@bcw-global.com anthony.fernandes@bcw-global.com ahmed.abdulrazek@bcw-global.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release

- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc

BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release

New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,

Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release

Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com

inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release

Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea

Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release

Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye